Breast cancer (BC) is the most frequent cancer diagnosed in women worldwide. This
heterogeneous disease can be classified into four molecular subtypes (luminal A, luminal B …

Importance Breast cancer will be diagnosed in 12% of women in the United States over the
course of their lifetimes and more than 250 000 new cases of breast cancer were diagnosed …

Prolidase (peptidase D), encoded by the PEPD gene, is a ubiquitously expressed cytosolic
metalloproteinase, the only enzyme capable of cleaving imidodipeptides containing C …

One of the most common cancers that occur in females is breast cancer. Despite the
significant leaps and bounds that have been made in treatment of breast cancer, the disease …

Since the discovery of the anticancer potential of ruthenium-based complexes, several
species were reported as promising candidates for the treatment of breast cancer, which …

Breast cancer is the most prevalent cancer in women, and it was hard to prevent or diagnose
at an early stage. Thus, it is imperative to develop advanced therapeutics for effective …

Background Breast cancer is the most prevalent cancer worldwide, with high morbidity and
mortality. Despite great advances in the therapeutic strategies, the survival rate in the past …

The treatment of breast cancer (BC) is a serious challenge due to its heterogeneous nature,
multidrug resistance (MDR), and limited therapeutic options. Nanoparticle-based drug …

Prolidase (PEPD) is the only hydrolase that cleaves the dipeptides containing C-terminal
proline or hydroxyproline-the rate-limiting step in collagen biosynthesis. However, the …

Immunotherapy is a highly emerging form of breast cancer therapy that enables clinicians to
target cancers with specific receptor expression profiles. Two popular immunotherapeutic …